Jim Simons's position in Novartis AG is currently worth $311 Million. That's 0.52% of their equity portfolio (18th largest holding). The first Novartis AG trade was made in Q3 2013. Since then Jim Simons bought shares 25 more times and sold shares on seventeen occasions. The stake costed the investor $241 Million, netting the investor a gain of 29% so far.